Avis Budget Group Announces Intention to Offer $500 Million of Senior Notes
September 10, 2024 07:26 ET
|
Avis Budget Group, Inc.
PARSIPPANY, N.J., Sept. 10, 2024 (GLOBE NEWSWIRE) -- Avis Budget Group, Inc. (NASDAQ: CAR) (the “Company”) announced today that its wholly-owned subsidiaries, Avis Budget Car Rental, LLC and Avis...
Business Insurance Honors CorVel with Two Awards in 2024
September 10, 2024 07:15 ET
|
CorVel Corp.
CorVel Corporation has won two 2024 Business Insurance awards: one for innovation in generative AI and another for “Claims Team of the Year” with O’Reilly
Draganfly Unveils New APEX Drone: The Next Evolution in Military and Law Enforcement Drone Systems
September 10, 2024 07:15 ET
|
Draganfly Inc
SASKATOON, Saskatchewan, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8A) (“Draganfly” or the “Company”), an award-winning, industry-leading drone solutions...
Aveanna to Participate at the Deutsche Bank Annual Leveraged Finance Conference
September 10, 2024 07:00 ET
|
Aveanna Healthcare Holdings, Inc
ATLANTA, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that its management team will attend the Deutsche Bank Annual Leveraged...
Lifecore Biomedical Appoints Brikkelle Thompson as Senior Vice President of Human Resources
September 10, 2024 07:00 ET
|
Lifecore Biomedical, Inc.
CHASKA, Minn., Sept. 10, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore” or the “Company”), a fully integrated contract development and manufacturing organization...
TransCode Therapeutics Announces Publication of Study with Lead Therapeutic Candidate Revealing Mechanisms Behind Candidate’s Preclinical Efficacy Against Metastatic Cancer
September 10, 2024 07:00 ET
|
TransCode Therapeutics, Inc.
TransCode Therapeutics Announces Publication of Study with Lead Therapeutic Candi-date Revealing Mechanisms Behind Candidate’s Preclinical Efficacy Against
Bitfarms Enhances Operations Teams
September 10, 2024 07:00 ET
|
Bitfarms Ltd.
-Appoints Alex Brammer to Senior Vice President of Global Mining Operations- -Promotes Benoit Gobeil to Chief Infrastructure Officer- -Separates Mining Operations into two divisions, Infrastructure...
C4 Therapeutics Announces Delivery of Second Development Candidate to Biogen
September 10, 2024 07:00 ET
|
C4 Therapeutics, Inc.
Milestone Results in $8 Million Payment to C4 Therapeutics WATERTOWN, Mass., Sept. 10, 2024 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical...
ACELYRIN, INC. Announces Positive Proof-of-Concept Data From Phase 1/2 Clinical Trial of Lonigutamab as a Subcutaneous Treatment for Thyroid Eye Disease to be Presented at 42nd Annual Meeting of European Society of Ophthalmic Plastic and Reconstructive Surgery
September 10, 2024 07:00 ET
|
ACELYRIN, INC.
Rapid-fire Oral Presentation to Highlight Efficacy, Safety, and Quality of Life Outcomes LOS ANGELES, Sept. 10, 2024 (GLOBE NEWSWIRE) -- ACELYRIN, INC. (Nasdaq: SLRN), a late-stage clinical...
Centessa Announces Positive Interim Phase 1 Clinical Data with its Novel Orexin Receptor 2 (OX2R) Agonist, ORX750, in Acutely Sleep-Deprived Healthy Volunteers
September 10, 2024 07:00 ET
|
Centessa Pharmaceuticals plc
2.5 mg dose restored normative wakefulness with mean sleep latency of 32 minutes as measured by the Maintenance of Wakefulness Test (MWT)Favorable safety and tolerability profile with no observations...